{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:06Z","timestamp":1792270926738,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cpm.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T13:21:48Z","timestamp":1540473708000},"page":"115-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Perioperative Management of the Rheumatoid Patient"],"prefix":"10.1016","volume":"36","author":[{"given":"Jesse","family":"Wolfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. John","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpm.2018.08.005_bib1","series-title":"Perioperative management of the patient with arthritis or systemic autoimmune disease. In medical management of the surgical patient","first-page":"633","author":"Mandell","year":"2008"},{"issue":"4","key":"10.1016\/j.cpm.2018.08.005_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12325-018-0686-0","article-title":"Perioperative management of patients with inflammatory rheumatic diseases undergoing major orthopaedic surgery: a practical overview","volume":"35","author":"Gualtierotti","year":"2018","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ca.22980","article-title":"Rheumatoid arthritis in review: clinical, anatomical, cellular and molecular points of view","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin Anat"},{"key":"10.1016\/j.cpm.2018.08.005_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1874312901307010042","article-title":"Perioperative management of patients with rheumatic diseases","volume":"7","author":"Bissar","year":"2013","journal-title":"Open Rheumatol J"},{"issue":"8","key":"10.1016\/j.cpm.2018.08.005_bib5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/acr.23274","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.cpm.2018.08.005_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/ard.2010.143560","article-title":"Performance of the 2010 ACR\/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort","volume":"70","author":"Cader","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.cpm.2018.08.005_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.21649","article-title":"Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice","volume":"64","author":"Anderson","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.cpm.2018.08.005_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard.2011.154625","article-title":"Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR\/EULAR remission criteria in an observational cohort","volume":"71","author":"Lillegraven","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"18","key":"10.1016\/j.cpm.2018.08.005_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM198411013111802","article-title":"Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study","volume":"311","author":"Kannel","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cpm.2018.08.005_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00003643-199911000-00002","article-title":"Usefulness of routine pre-operative chest radiography for anaesthetic management: a prospective multicentre pilot study","volume":"11","author":"Silvestri","year":"1999","journal-title":"Eur J Anaesthesiol"},{"issue":"10","key":"10.1016\/j.cpm.2018.08.005_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","article-title":"Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery","volume":"100","author":"Lee","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpm.2018.08.005_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5435\/00124635-200804000-00005","article-title":"Perioperative medical comorbidities in the orthopaedic patient","volume":"16","author":"Bushnell","year":"2008","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.spinee.2003.10.006","article-title":"Rheumatoid arthritis of the cervical spine","volume":"4","author":"Nguyen","year":"2004","journal-title":"Spine J"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF03011313","article-title":"Rheumatoid cervical joint disease\u2014a challenge to the anaesthetist","volume":"40","author":"Macarthur","year":"1993","journal-title":"Can J Anaesth"},{"issue":"24","key":"10.1016\/j.cpm.2018.08.005_bib16","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1097\/00007632-199812150-00017","article-title":"Inflammatory disorders of the cervical spine","volume":"23","author":"Reiter","year":"1998","journal-title":"Spine (Phila Pa 1976)"},{"issue":"272","key":"10.1016\/j.cpm.2018.08.005_bib17","first-page":"127","article-title":"Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty","author":"Collins","year":"1991","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2106\/00004623-198163030-00003","article-title":"A\u00a0prospective study of the progression of rheumatoid arthritis of the cervical spine","volume":"63","author":"Pellicci","year":"1981","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.cpm.2018.08.005_bib19","series-title":"The cervical spine","first-page":"705","article-title":"Rheumatoid arthritis, upper cervical involvement","author":"Crockard","year":"1998"},{"issue":"7","key":"10.1016\/j.cpm.2018.08.005_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF03017454","article-title":"Cricoarytenoid arthritis: a cause of acute upper airway obstruction in rheumatoid arthritis","volume":"49","author":"Kolman","year":"2002","journal-title":"Can J Anaesth"},{"issue":"12","key":"10.1016\/j.cpm.2018.08.005_bib21","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.cpm.2018.08.005_bib22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2009.124362","article-title":"Increased prevalence of diastolic dysfunction in rheumatoid arthritis","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.cpm.2018.08.005_bib25","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00296-018-4053-x","article-title":"Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity","volume":"38","author":"Biskup","year":"2018","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"02","key":"10.1016\/j.cpm.2018.08.005_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0034-1371542","article-title":"Rheumatoid arthritis and lung disease: from mechanisms to a practical approach","volume":"35","author":"Lake","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.cpm.2018.08.005_bib28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.cpm.2018.08.005_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl_6","key":"10.1016\/j.cpm.2018.08.005_bib30","first-page":"vi37","article-title":"Overview of safety of non-biologic and biologic DMARDs","volume":"51","author":"Ruderman","year":"2012","journal-title":"Rheumatology"},{"issue":"suppl_6","key":"10.1016\/j.cpm.2018.08.005_bib31","first-page":"vi28","article-title":"Evolution of treatment for rheumatoid arthritis","volume":"51","author":"Upchurch","year":"2012","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.cpm.2018.08.005_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/1744666X.2013.811173","article-title":"Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis","volume":"9","author":"Atzeni","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.cpm.2018.08.005_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.foot.2017.01.009","article-title":"The implications of biologic therapy for elective foot and ankle surgery in patients with rheumatoid arthritis","volume":"30","author":"Diaper","year":"2017","journal-title":"Foot (Edinb)"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3899\/jrheum.111056","article-title":"Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality","volume":"39","author":"Shourt","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.cpm.2018.08.005_bib35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cpm.2018.08.005_bib36","doi-asserted-by":"crossref","first-page":"w14563","DOI":"10.4414\/smw.2017.14563","article-title":"The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis","volume":"147","author":"Fleury","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib37","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate","volume":"65","author":"Tian","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"9","key":"10.1016\/j.cpm.2018.08.005_bib38","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/art.22032","article-title":"Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis","volume":"54","author":"Wessels","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5414\/CP202242","article-title":"Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients","volume":"53","author":"Saleh","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cpm.2018.08.005_bib40","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.semarthrit.2015.01.008","article-title":"Rheumatoid arthritis: perioperative management of biologics and DMARDs","volume":"44","author":"Goodman","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.60.3.214","article-title":"Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery","volume":"60","author":"Grennan","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.cpm.2018.08.005_bib42","first-page":"1129","article-title":"Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis","volume":"20","author":"Sany","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.cpm.2018.08.005_bib43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/41.7.741","article-title":"Methotrexate in the treatment of rheumatoid arthritis. II. In\u00a0vivo effects on bone mineral density","volume":"41","author":"Minaur","year":"2002","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib44","first-page":"251","article-title":"Methotrexate (MTX) inhibits osteoblastic differentiation in\u00a0vitro: possible mechanism of MTX osteopathy","volume":"28","author":"Uehara","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1746-160X-8-26","article-title":"Short time administration of antirheumatic drugs\u2014methotrexate as a strong inhibitor of osteoblast's proliferation in\u00a0vitro","volume":"8","author":"Annussek","year":"2012","journal-title":"Head Face Med"},{"issue":"112","key":"10.1016\/j.cpm.2018.08.005_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/030097499750042245-1","article-title":"Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis","volume":"28","author":"Smolen","year":"1999","journal-title":"Scand J Rheumatol"},{"issue":"suppl_2","key":"10.1016\/j.cpm.2018.08.005_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/XXXIV.suppl_2.7","article-title":"Sulphasalazine: mechanism of action in rheumatoid arthritis","volume":"34","author":"Smedeg\u00e5rd","year":"1995","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.cpm.2018.08.005_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/tpj.2013.45","article-title":"Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis","volume":"14","author":"Wiese","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/rheumatology\/36.3.382","article-title":"Sulphasalazine in the treatment of rheumatoid arthritis","volume":"36","author":"Box","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"10","key":"10.1016\/j.cpm.2018.08.005_bib50","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: closing the gate on toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","article-title":"Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"77","author":"Rempenault","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ci049754d","article-title":"Molecular modeling study of leflunomide and its active metabolite analogues","volume":"45","author":"Panek","year":"2005","journal-title":"J\u00a0Chem Inf Model"},{"issue":"21","key":"10.1016\/j.cpm.2018.08.005_bib53","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate","volume":"159","author":"Strand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpm.2018.08.005_bib54","unstructured":"Fox R, Helfgott SM. Pharmacology, dosing, and adverse effects of leflunomide in the treatment of rheumatoid arthritis. In: Romain PL, editor. UpToDate. Available at: https:\/\/www.uptodate.com\/contents\/pharmacology-dosing-and-adverse-effects-of-leflunomide-in-the-treatment-of-rheumatoid-arthritis. Accessed July 16, 2018."},{"issue":"9","key":"10.1016\/j.cpm.2018.08.005_bib55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5435\/00124635-200609000-00004","article-title":"Perioperative medication management for the patient with rheumatoid arthritis","volume":"14","author":"Howe","year":"2006","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"12","key":"10.1016\/j.cpm.2018.08.005_bib56","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s00296-006-0138-z","article-title":"Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery","volume":"26","author":"Fuerst","year":"2006","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.cpm.2018.08.005_bib57","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/acr.23185","article-title":"\u201cOfficial View\u201d on glucocorticoids in rheumatoid arthritis: a systematic review of international guidelines and consensus statements","volume":"69","author":"Palmowski","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.cpm.2018.08.005_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1874312920131210005","article-title":"Risk factors for infection following total joint arthroplasty in rheumatoid arthritis","volume":"7","author":"Somayaji","year":"2013","journal-title":"Open Rheumatol J"},{"issue":"20","key":"10.1016\/j.cpm.2018.08.005_bib59","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.cpm.2018.08.005_bib60","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six\u2013month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1749-799X-7-27","article-title":"Lower limb joint replacement in rheumatoid arthritis","volume":"7","author":"Clement","year":"2012","journal-title":"J\u00a0Orthop Surg Res"},{"issue":"5","key":"10.1016\/j.cpm.2018.08.005_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2006.10.003","article-title":"Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment?","volume":"36","author":"Pieringer","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.cpm.2018.08.005_bib63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12178-013-9178-7","article-title":"The rheumatoid forefoot","volume":"6","author":"Brooks","year":"2013","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cpm.2010.02.001","article-title":"Perioperative management of the patient with rheumatoid arthritis","volume":"27","author":"Jacobs","year":"2010","journal-title":"Clin Podiatr Med Surg"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/107110070302400210","article-title":"Injury characteristics and the clinical outcome of subtalar dislocations: a clinical and radiographic analysis of 25 cases","volume":"24","author":"Bibbo","year":"2003","journal-title":"Foot Ankle Int"},{"issue":"8","key":"10.1016\/j.cpm.2018.08.005_bib66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/107110070602700804","article-title":"Long-term results after metatarsal head resection in the treatment of rheumatoid arthritis","volume":"27","author":"Reize","year":"2006","journal-title":"Foot Ankle Int"},{"issue":"3","key":"10.1016\/j.cpm.2018.08.005_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.fas.2005.03.003","article-title":"Tibiotalocalcaneal fusion using retrograde intramedullary nails as a salvage procedure for failed total ankle prostheses in rheumatoid arthritis: a report on sixteen cases","volume":"11","author":"Anderson","year":"2005","journal-title":"Foot Ankle Surg"},{"issue":"4\u20135","key":"10.1016\/j.cpm.2018.08.005_bib68","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.berh.2015.09.004","article-title":"Arthroplasty in patients with established rheumatoid arthritis (RA): mitigating risks and optimizing outcomes","volume":"29","author":"Goodman","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.cpm.2018.08.005_bib69","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/annrheumdis-2013-203380","article-title":"Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study","volume":"73","author":"Chung","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.cpm.2018.08.005_bib70","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T\u00a0cell expansion by paradoxically promoting membrane TNF\u2013TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cpm.2018.08.005_bib71","first-page":"183","article-title":"Infliximab in the treatment of rheumatoid arthritis","volume":"3","author":"Perdriger","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.cpm.2018.08.005_bib72","first-page":"79","article-title":"Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis","volume":"3","author":"Michelon","year":"2010","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/mabs.2.2.11271","article-title":"Certolizumab pegol","volume":"2","author":"Goel","year":"2010","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0149-2918(00)88269-7","article-title":"Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.cpm.2018.08.005_bib75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reuma.2011.08.002","article-title":"Abatacept mechanism of action: concordance with its clinical profile","volume":"8","author":"Herrero-Beaumont","year":"2012","journal-title":"Reumatol Clin"},{"issue":"6","key":"10.1016\/j.cpm.2018.08.005_bib76","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.cpm.2018.08.005_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"Jones","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.cpm.2018.08.005_bib78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3899\/jrheum.130683","article-title":"Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, long-term extension studies","volume":"41","author":"Wollenhaupt","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.cpm.2018.08.005_bib79","doi-asserted-by":"crossref","first-page":"386","DOI":"10.6061\/clinics\/2017(06)09","article-title":"Perioperative management of drugs commonly used in patients with rheumatic diseases: a review","volume":"72","author":"Franco","year":"2017","journal-title":"Clinics (Sao Paulo)"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842218300569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842218300569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:58:21Z","timestamp":1760209101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842218300569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0891842218300569"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2018.08.005","relation":{},"ISSN":["0891-8422"],"issn-type":[{"value":"0891-8422","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Management of the Rheumatoid Patient","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}